Certificate of Analysis
BPC-157/TB-500(TB-4) 10/10mg
Lot PUR-10/26 · Accession KVR-2026-53A8FD
Purity
99.66%
Net content
22.51 mg
Identity
BPC-157/TB-500(TB-4)
Appearance
Lyophilized Powder
Per-vial results
| Vial | Purity | Net content |
|---|---|---|
| 1 | 99.84% | 22.45 mg |
| 2 | 99.64% | 22.17 mg |
| 3 | 99.54% | 23.08 mg |
| 4 | 99.61% | 22.34 mg |
Blend composition
- BPC-15711.51 mglabelled 10 mg
- TB-500(TB-4)10.94 mglabelled 10 mg
Safety testing
- Endotoxin
- Pass
- Endotoxin limit
- ≤0.5 EU/mL
- Microbial
- No Growth
- Fentanyl screen
- Not Detected
Provenance
- Laboratory
- Kovera Labs
- Certificate
- KVR-2026-53A8FD
- Lot
- PUR-10/26
- Cap
- Purple (PUR)
- Crimp
- Silver
- Reported
- 2026-10-13
Verify independently at koveralabs.com/verify using access code JC5ROW8.